Moderna announced Monday that a booster dose of its vaccine significantly raised antibody levels that protect against the Omicron variant.
A booster dose of the vaccine, which is half the dose originally used in the shots for adults, increased antibody levels against Omicron by a factor of 37, according to preliminary company data, per Just the News.
Paul Burton, the company’s chief medical officer, said the booster’s protections “should provide some good level of protection as we go into the holiday season.”
A double dose size of the normal booster was shown to raise antibody levels by 83 times. While the booster is a half-size dose, the full-size was given to immunocompromised people for utmost protection.
Currently, about half of the country’s coronavirus cases are the Omicron variant.
